awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47813600-0F295616-B13F-4627-965E-C711771E2003
Q47813600-0F295616-B13F-4627-965E-C711771E2003
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47813600-0F295616-B13F-4627-965E-C711771E2003
Network meta-analysis of second-line treatment in metastatic renal cell carcinoma: efficacy and safety.
P2860
Q47813600-0F295616-B13F-4627-965E-C711771E2003
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47813600-0F295616-B13F-4627-965E-C711771E2003
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
53dac6de7b750f6daf01255b97c0e90e5fd97641
P2860
Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial